Canadian marijuana giant Canopy Growth has acquired Germany-based C3 Cannabinoid Compound Co. from Bionorica in an all-cash deal for 226 million euros ($253 million).
Alfredo Pascual
Alfredo Pascual's Latest Posts
Germany authorizes medical cannabis shipments from Latin America for testing, paving way for future opportunities
The first cannabis shipments from Latin America to Europe have been approved, a move that could lay the groundwork for future business opportunities between the two regions. Cansativa GmbH, a German importer of medical cannabis that currently sources product only from...
Netherlands to expand cannabis production, potentially creating competition for Bedrocan
The Netherlands is taking steps to boost the country’s medical cannabis cultivation, a move that could end Dutch cultivator Bedrocan’s longstanding monopoly position for supplying the country.
Ways for marijuana firms to protect their stocks from short sellers
Short sellers have been under attack for years, going as far back as the 1929 stock market crash or as recently as Tesla CEO Elon Musk’s charge that short sellers as “jerks who want us to die.”
Luxembourg’s medical cannabis program continues rapid implementation
Luxembourg's medical marijuana program - approved in June 2018 - continues its fast-paced implementation, as 250 doctors have already completed the required training to prescribe the product. Roughly two-thirds of those doctors are generalists. [include_post...
Aphria, Wayland face challenge over German marijuana cultivation contracts
Germany’s efforts to get domestic cultivation up and running took another step forward today, as the German Federal Institute for Drugs and Medical Devices confirmed the winners of nine of the 13 available lots for the first round.
Brazilian cannabis import authorizations top 1,000 in the first quarter of 2019
Brazilian authorities continued to approve permits to import medical cannabis at an increasing rate through the first quarter of 2019. According to data provided to Marijuana Business Daily, Brazil's National Sanitary Surveillance Agency (ANVISA) granted 884 new...
Aphria reports CA$108 million loss on lower marijuana sales
Despite a sharp increase in revenue, Ontario-based Aphria’s third-quarter 2018 profit of 12.9 million Canadian dollars ($9.6 million) turned into a net loss of CA$108.2 million for the third quarter of fiscal 2019.
Aphria, Aurora and Demecan selected for German medical cannabis cultivation
Three companies were chosen to cultivate medical marijuana in Germany – the result of a long-delayed application process to provide product for one of the largest medical cannabis markets in the world.
European cannabis leader Bedrocan to reenter Canada, South America
Dutch medical marijuana giant Bedrocan International is poised for an early return to Canada and South America after an arbitration tribunal reduced the duration of a moratorium prohibiting the company from those markets.
Mexico revokes cannabis guidelines, throwing licenses into doubt
Mexico’s main regulatory body for medical cannabis revoked key guidelines used as the basis for issuing dozens of import licenses for low-THC products, putting the status of those permits into question, pending a government review.
Insurance-covered cannabis in Germany tops 70 million euros in 2018
Statutory health insurers in Germany covered 73.7 million euros ($83.7 million) worth of medical cannabis products in 2018, according to new data published by German health insurance agency GKV-Spitzenverband. Pharmacies in the country...
